InsightfulValue
← Home

Takeda Pharmaceutical
Takeda Pharmaceutical

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (2)
Takeda Pharmaceutical

πŸ“Š Get full analytics about Takeda Pharmaceutical

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
Takeda Pharmaceutical Company Limited is a global, research-based pharmaceutical company headquartered in Japan. The company was founded in 1781 and has a rich history of over 200 years of continuous operation.
Takeda is one of the world's largest pharmaceutical companies, with a focus on developing and delivering innovative medicines to patients in more than 80 countries and regions around the world. The company's research and development efforts are focused on four therapeutic areas: oncology, gastroenterology, neurology, and rare diseases.
With a commitment to improving the health and well-being of people worldwide, Takeda strives to develop safe and effective medicines to treat a wide range of diseases and conditions. In addition to its core therapeutic areas, the company also has a growing portfolio in vaccines and consumer healthcare.
Takeda's corporate philosophy, "Takeda-ism," emphasizes its dedication to ethical and responsible business practices, as well as its commitment to patients, employees, and the global community.
Today, Takeda has a team of more than 49,000 employees worldwide, and its research and development efforts are led by a diverse network of scientists, researchers, and physicians who collaborate globally to drive innovation and advancement in the pharmaceutical industry.
What is special about the company?
Takeda Pharmaceutical

πŸ“ˆ Want to read more about Takeda Pharmaceutical?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlcmUgYX JlIHNldmVy YWwgYXNwZW N0cyB0aGF0 IG1ha2UgVG FrZWRhIFBo YXJtYWNldX RpY2FsIHN0 YW5kIG91dC BhcyBhIGNv bXBhbnk6PG JyPjEuIExv bmcgSGlzdG 9yeTogVGFr ZWRhIFBoYX JtYWNldXRp Y2FsIHdhcy Bmb3VuZGVk IGluIDE3OD EsIG1ha2lu ZyBpdCBvbm Ugb2YgdGhl IG9sZGVzdC Bjb21wYW5p ZXMgaW4gSm FwYW4gYW5k IHRoZSB3b3 JsZC4gVGhp cyBsb25nIG hpc3Rvcnkg aGFzIGFsbG 93ZWQgdGhl IGNvbXBhbn kgdG8gZ2Fp biBleHRlbn NpdmUga25v d2xlZGdlIG FuZCBleHBl cmllbmNlIG luIHRoZSBw aGFybWFjZX V0aWNhbCBp bmR1c3RyeS 48YnI+Mi4g SW50ZXJuYX Rpb25hbCBQ cmVzZW5jZT ogVGFrZWRh IGhhcyBhIH N0cm9uZyBn bG9iYWwgcH Jlc2VuY2Us IHdpdGggb3 BlcmF0aW9u cyBpbiBvdm VyIDgwIGNv dW50cmllcy BhbmQgcmVn aW9ucyB3b3 JsZHdpZGUu IEl0IGhhcy BhIHN0cm9u ZyBmb2N1cy BvbiBlbWVy Z2luZyBtYX JrZXRzLCBl c3BlY2lhbG x5IGluIEFz aWEsIHdoZX JlIHRoZSBj b21wYW55IG hhcyBhIGxl YWRpbmcgcG 9zaXRpb24g aW4gdGhlIH BoYXJtYWNl dXRpY2FsIG luZHVzdHJ5 Ljxicj4zLi BEaXZlcnNl IFBvcnRmb2 xpbzogVGFr ZWRhIGhhcy BhIGRpdmVy c2UgcG9ydG ZvbGlvIG9m IHByb2R1Y3 RzLCBjb3Zl cmluZyBhIH dpZGUgcmFu Z2Ugb2YgdG hlcmFwZXV0 aWMgYXJlYX MsIGluY2x1 ZGluZyBvbm NvbG9neSwg Z2FzdHJvZW 50ZXJvbG9n eSwgbmV1cm 9zY2llbmNl LCByYXJlIG Rpc2Vhc2Vz LCBhbmQgdm FjY2luZXMu IFRoaXMgZG l2ZXJzaWZp Y2F0aW9uIG hlbHBzIHRo ZSBjb21wYW 55IG1pdGln YXRlIHJpc2 tzIGFuZCBt YWludGFpbi BhIHN0YWJs ZSByZXZlbn VlIHN0cmVh bS48YnI+NC 4gSW5ub3Zh dGlvbjogVG FrZWRhIGhh cyBhIHN0cm 9uZyBmb2N1 cyBvbiByZX NlYXJjaCBh bmQgZGV2ZW xvcG1lbnQg KFImRCksIH dpdGggYSBz aWduaWZpY2 FudCBpbnZl c3RtZW50IG luIGN1dHRp bmctZWRnZS B0ZWNobm9s b2d5IGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIGV4 dGVybmFsIH BhcnRuZXJz LiBUaGUgY2 9tcGFueSBh bHNvIGhhcy BhIHJvYnVz dCBwaXBlbG luZSBvZiBw b3RlbnRpYW wgbmV3IHRy ZWF0bWVudH MsIGVuc3Vy aW5nIGl0cy Bsb25nLXRl cm0gZ3Jvd3 RoLjxicj41 LiBDb3Jwb3 JhdGUgU29j aWFsIFJlc3 BvbnNpYmls aXR5OiBUYW tlZGEgaXMg Y29tbWl0dG VkIHRvIGNv cnBvcmF0ZS ByZXNwb25z aWJpbGl0eS BhbmQgaGFz IHNldCBhbW JpdGlvdXMg Z29hbHMgdG 8gcmVkdWNl IGl0cyBlbn Zpcm9ubWVu dGFsIGltcG FjdCBhbmQg aW1wcm92ZS BhY2Nlc3Mg dG8gaGVhbH RoY2FyZSBn bG9iYWxseS 4gVGhlIGNv bXBhbnkgYW xzbyBoYXMg dmFyaW91cy Bwcm9ncmFt cyBpbiBwbG FjZSB0byBz dXBwb3J0IG NvbW11bml0 aWVzIGFuZC Bwcm9tb3Rl IGRpdmVyc2 l0eSBhbmQg aW5jbHVzaW 9uLjxicj42 LiBWYWx1ZX MtRHJpdmVu IEN1bHR1cm U6IFRha2Vk YSdzIGNvcm UgdmFsdWVz LCBzdWNoIG FzICJpbnRl Z3JpdHksIG ZhaXJuZXNz LCBhbmQgaG 9uZXN0eSIg YW5kICJwdX R0aW5nIHRo ZSBwYXRpZW 50IGZpcnN0 LCIgYXJlIG RlZXBseSBp bmdyYWluZW QgaW4gaXRz IGNvcnBvcm F0ZSBjdWx0 dXJlLiBUaG lzIHN0cm9u ZyBldGhpY2 FsIGZvdW5k YXRpb24gZ3 VpZGVzIHRo ZSBjb21wYW 55J3MgZGVj aXNpb24tbW FraW5nIGFu ZCBkcml2ZX MgaXRzIGNv bW1pdG1lbn QgdG8gbWFr aW5nIGEgcG 9zaXRpdmUg aW1wYWN0IG luIHRoZSB3 b3JsZC48Yn I+SW4gY29u Y2x1c2lvbi wgVGFrZWRh IFBoYXJtYW NldXRpY2Fs J3MgbG9uZy BoaXN0b3J5 LCBnbG9iYW wgcHJlc2Vu Y2UsIGRpdm Vyc2UgcG9y dGZvbGlvLC Bmb2N1cyBv biBpbm5vdm F0aW9uLCBj b21taXRtZW 50IHRvIHNv Y2lhbCByZX Nwb25zaWJp bGl0eSwgYW 5kIHZhbHVl cy1kcml2ZW 4gY3VsdHVy ZSBhbGwgbW FrZSBpdCBh IHVuaXF1ZS BhbmQgc3Vj Y2Vzc2Z1bC Bjb21wYW55 IGluIHRoZS BwaGFybWFj ZXV0aWNhbC BpbmR1c3Ry eS4=
What the company's business model?
Takeda Pharmaceutical

πŸ“ˆ Want to read more about Takeda Pharmaceutical?

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIFRha2 VkYSBQaGFy bWFjZXV0aW NhbCBjb21w YW55J3MgYn VzaW5lc3Mg bW9kZWwgaX MgYmFzZWQg b24gcmVzZW FyY2hpbmcs IGRldmVsb3 BpbmcsIG1h bnVmYWN0dX JpbmcsIGFu ZCBtYXJrZX RpbmcgcGhh cm1hY2V1dG ljYWwgcHJv ZHVjdHMuIF RoZSBjb21w YW55IGZvY3 VzZXMgb24g dGhlIGZvbG xvd2luZyBr ZXkgYXJlYX M6PGJyPjEu IFJlc2Vhcm NoIGFuZCBk ZXZlbG9wbW VudDogVGFr ZWRhIGludm VzdHMgaGVh dmlseSBpbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQgdG8gZG lzY292ZXIg YW5kIGRldm Vsb3AgbmV3 IG1lZGljaW 5lcyBmb3Ig ZGlzZWFzZX Mgd2l0aCBo aWdoIHVubW V0IG1lZGlj YWwgbmVlZH MuPGJyPjIu IE1hbnVmYW N0dXJpbmc6 IFRha2VkYS BoYXMgYSBn bG9iYWwgbm V0d29yayBv ZiBtYW51Zm FjdHVyaW5n IGZhY2lsaX RpZXMgdG8g cHJvZHVjZS BpdHMgcGhh cm1hY2V1dG ljYWwgcHJv ZHVjdHMgYX QgaGlnaCBx dWFsaXR5IG FuZCBlZmZp Y2llbmN5Lj xicj4zLiBN YXJrZXRpbm cgYW5kIHNh bGVzOiBUYW tlZGEgbWFy a2V0cyBhbm Qgc2VsbHMg aXRzIHByb2 R1Y3RzIHRv IGhlYWx0aG NhcmUgcHJv ZmVzc2lvbm FscyBhbmQg cGF0aWVudH MgZ2xvYmFs bHkgdGhyb3 VnaCB2YXJp b3VzIGNoYW 5uZWxzLCBp bmNsdWRpbm cgc2FsZXMg cmVwcmVzZW 50YXRpdmVz LCBkaWdpdG FsIG1hcmtl dGluZywgYW 5kIHBhcnRu ZXJzaGlwcy B3aXRoIGhl YWx0aGNhcm Ugb3JnYW5p emF0aW9ucy 48YnI+NC4g RGl2ZXJzaW ZpY2F0aW9u OiBUYWtlZG EgaGFzIGEg ZGl2ZXJzZS Bwb3J0Zm9s aW8gb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IHJhbmdpbm cgZnJvbSBw cmVzY3JpcH Rpb24gbWVk aWNpbmVzIH RvIG92ZXIt dGhlLWNvdW 50ZXIgYW5k IGNvbnN1bW VyIGhlYWx0 aGNhcmUgcH JvZHVjdHMu PGJyPjUuIE dlb2dyYXBo aWMgZXhwYW 5zaW9uOiBU YWtlZGEgb3 BlcmF0ZXMg aW4gb3Zlci A4MCBjb3Vu dHJpZXMgYW 5kIGNvbnRp bnVlcyB0by BleHBhbmQg aXRzIHByZX NlbmNlIGlu IGVtZXJnaW 5nIG1hcmtl dHMsIHBhcn RpY3VsYXJs eSBpbiBBc2 lhIGFuZCBM YXRpbiBBbW VyaWNhLjxi cj42LiBTdH JhdGVnaWMg cGFydG5lcn NoaXBzIGFu ZCBhY3F1aX NpdGlvbnM6 IFRha2VkYS Bjb2xsYWJv cmF0ZXMgd2 l0aCBvdGhl ciBwaGFybW FjZXV0aWNh bCBjb21wYW 5pZXMgYW5k IHJlc2Vhcm NoIGluc3Rp dHV0aW9ucy B0byBkZXZl bG9wIG5ldy B0cmVhdG1l bnRzIGFuZC B0ZWNobm9s b2dpZXMuIF RoZSBjb21w YW55IGFsc2 8gYWNxdWly ZXMgb3RoZX IgY29tcGFu aWVzIHRvIG V4cGFuZCBp dHMgcHJvZH VjdCBwb3J0 Zm9saW8gYW 5kIGdlb2dy YXBoaWMgcm VhY2guPGJy PjcuIFBhdG llbnQtY2Vu dHJpYyBhcH Byb2FjaDog VGFrZWRhIG ZvY3VzZXMg b24gdW5kZX JzdGFuZGlu ZyBwYXRpZW 50cycgbmVl ZHMgYW5kIH dvcmtzIHRv IGRldmVsb3 AgdHJlYXRt ZW50cyB0aG F0IG1lZXQg dGhvc2Ugbm VlZHMuIFRo ZSBjb21wYW 55IGFsc28g aW52ZXN0cy BpbiBwYXRp ZW50IGVkdW NhdGlvbiBh bmQgYWNjZX NzIHByb2dy YW1zIHRvIG 1ha2UgdHJl YXRtZW50cy Btb3JlIGFj Y2Vzc2libG UgdG8gdGhv c2UgaW4gbm VlZC48YnI+ T3ZlcmFsbC wgVGFrZWRh J3MgYnVzaW 5lc3MgbW9k ZWwgaXMgY2 VudGVyZWQg b24gaW5ub3 ZhdGlvbiwg c3RyYXRlZ2 ljIHBhcnRu ZXJzaGlwcy wgYW5kIGEg cGF0aWVudC 1jZW50cmlj IGFwcHJvYW NoIHRvIGJy aW5nIGxpZm UtY2hhbmdp bmcgbWVkaW NpbmVzIHRv IHBlb3BsZS Bhcm91bmQg dGhlIHdvcm xkLg==
Interesting facts about the company
Takeda Pharmaceutical

πŸ“ˆ Want to read more about Takeda Pharmaceutical?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVz hVeWd5Y2dj ekVBMVhsRE 5nNjIud2Vi cCIgYWx0PS JUYWtlZGEg UGhhcm1hY2 V1dGljYWwi IHRpdGxlPS JUYWtlZGEg UGhhcm1hY2 V1dGljYWwi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgVGFrZWRh IFBoYXJtYW NldXRpY2Fs PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TmiBZ b3VyIGZyZW UgY29weSBv ZiA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGlz IHdhaXRpbm cKICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9wPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxMnB4 OyBmb250LX NpemU6IDEz cHg7IGNvbG 9yOiAjNDQ0 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIG5vdyBh bmQgZ2V0IG 91ciBmcmVl IGVCb29rIA ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG I+VGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrczwvYj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDE2cHg7IG ZvbnQtc2l6 ZTogMTRweD sgY29sb3I6 ICM0NDQ7IG ZvbnQtZmFt aWx5OiAtYX BwbGUtc3lz dGVtLCBCbG lua01hY1N5 c3RlbUZvbn QsIFNlZ29l IFVJLCBSb2 JvdG8sIEhl bHZldGljYS BOZXVlLCBz YW5zLXNlcm lmOyBsaW5l LWhlaWdodD ogMS42Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBI YXZlIHlvdS BoZWFyZCBh Ym91dCBvdX Igc2hvcnQg PHN0cm9uZy BzdHlsZT0n Zm9udC13ZW lnaHQ6IDYw MDsnPkRhaW x5IFZpZGVv IE5ld3NsZX R0ZXI8L3N0 cm9uZz4/Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdo dHRwczovL3 d3dy5pbnNp Z2h0ZnVsdm FsdWUuY29t L25ld3NsZX R0ZXIucGhw JyB0YXJnZX Q9J19ibGFu aycgc3R5bG U9J2NvbG9y OiAjMDA3Qk ZGOyB0ZXh0 LWRlY29yYX Rpb246IG5v bmU7IGZvbn Qtd2VpZ2h0 OiA1MDA7IG 1hcmdpbi1s ZWZ0OiA2cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBG aW5kIG91dC Btb3JlCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgCi AgICAgICAg CiAgICAgIC AgPHNwYW4g Y2xhc3M9J2 JsdXJyZWQt dGV4dCc+Ci AgICAgICAg ICAgIE1TNG dWR0ZyWlcg UmhJRkJvWV hKdCBZV05s ZFhScFkyIE ZzSUdseklH RWcgU21Gd1 lXNWxjMiBV Z2JYVnNkR2 x1IFlYUnBi MjVoYkMgQn dhR0Z5YldG aiBaWFYwYV dOaGJDIEJq YjIxd1lXNT UgTENCb1pX RmtjWCBWaG NuUmxjbVZr IElHbHVJRl J2YTMgbHZM Q0JLWVhCaC BiaTRnU1hR Z2FYIE1nYj I1bElHOW0g SUhSb1pTQn NZWCBKblpY TjBJSEJvIF lYSnRZV05s ZFggUnBZMk ZzSUdOdiBi WEJoYm1sbG N5IEJwYmlC MGFHVWcgZD I5eWJHUWdZ biBrZ2NtVj JaVzUxIFpT NDhZbkkrTW kgNGdWR2hs SUdOdiBiWE JoYm5rZ2Qy IEZ6SUdadm RXNWsgWldR Z2FXNGdNVC BjNE1TQmll U0JEIGFHOW laV2tnVkcg RnJaV1JoSU VrZyBZVzVr SUhkaGN5IE JwYm1sMGFX RnMgYkhrZ1 kyRnNiRyBW a0lGUmhhMl ZrIFlTQkRh RzlpWlcga2 dVR2hoY20x aCBZMlYxZE dsallXIHdn VTJodmNDNG cgU1hRZ2Qy RnpJRyBFZ2 MyMWhiR3dn IGNHaGhjbT FoWTMga2dh VzRnUkc5ei BhRzl0WVdO b2FTIHdnVD NOaGEyRXMg SUVwaGNHRn VMaiB4aWNq NHpMaUJVIF lXdGxaR0Vn VUcgaGhjbT FoWTJWMSBk R2xqWVd3Z1 ltIFZqWVcx bElHRWcgY0 hWaWJHbGpJ RyBOdmJYQm hibmtnIGFX NGdNVGswT1 MgQmhibVFn ZDJGeiBJR3 hwYzNSbFpD IEJ2YmlCMG FHVWcgVkc5 cmVXOGdVMy BSdlkyc2dS WGhqIGFHRn VaMlV1UEcg SnlQalF1SU ZSaCBhMlZr WWVLQW1YIE 1nYldGcGJp Qm0gYjJOMW N5QnBjeSBC eVpYTmxZWE pqIGFDQmhi bVFnWkcgVj JaV3h2Y0cx bCBiblFnYV c0Z2RHIGhs SUdacFpXeG sgY3lCdlpp QnZibSBOdm JHOW5lU3dn IFoyRnpkSE p2WlcgNTBa WEp2Ykc5bi BlU3dnWVc1 a0lHIE5sYm 5SeVlXd2cg Ym1WeWRtOT FjeSBCemVY TjBaVzBnIF pHbHpiM0pr WlggSnpMaU JKZENCaCBi SE52SUhCeW IyIFIxWTJW eklIWmggWT JOcGJtVnpJ RyBGdVpDQn ZkbVZ5IExY Um9aUzFqYj MgVnVkR1Z5 SUcxbCBaR2 xqWVhScGIy IDV6TGp4aW NqNDEgTGlC VWFHVWdZMi A5dGNHRnVl U0JvIFlYTW dZU0JuYkcg OWlZV3dnY0 hKbCBjMlZ1 WTJVc0lIIG RwZEdnZ2Iz QmwgY21GMG FXOXVjeSBC cGJpQnZkbV Z5IElEZ3dJ R052ZFcgNT BjbWxsY3lC aCBibVFnY2 1WbmFXIDl1 Y3l3Z2FXNW ogYkhWa2FX NW5JSCBSb1 pTQlZibWww IFpXUWdVM1 JoZEcgVnpM Q0JGZFhKdi BjR1VzSUdG dVpDIEJCYz JsaExqeGkg Y2o0MkxpQl VZVyB0bFpH RWdhR0Z6IE lHRWdjM1J5 YjIgNW5JR0 52YlcxcCBk RzFsYm5RZ2 RHIDhnYzNW emRHRnAgYm 1GaWFXeHBk SCBrZ1lXNW tJSGRoIGN5 QnNhWE4wWl cgUWdhVzRn ZEdobCBJRV J2ZHlCS2Iy IDVsY3lCVG RYTjAgWVds dVlXSnBiRy BsMGVTQkpi bVJwIFkyVn pJR1p2Y2kg QXhNU0JqYj I1eiBaV04x ZEdsMlpTIE I1WldGeWN5 NDggWW5JK0 55NGdTVyA0 Z01qQXdPQ3 dnIFZHRnJa V1JoSUcgRm pjWFZwY21W ayBJRTFwYk d4bGJtIDVw ZFcwZ1VHaG ggY20xaFky VjFkRyBsal lXeHpMQ0Jo IElHeGxZV1 JwYm0gY2dZ bWx2Y0doaC BjbTFoWTJW MWRHIGxqWV d3Z1kyOXQg Y0dGdWVTQm 1iMiBOMWMy VmtJRzl1IE lIUm9aU0Jr WlggWmxiRz l3YldWdSBk Q0J2WmlCdm JtIE52Ykc5 bmVTQjAgY2 1WaGRHMWxi biBSekxqeG ljajQ0IExp QlVZV3RsWk cgRWdhWE1n YVc1MiBiMn gyWldRZ2FX IDRnZG1GeW FXOTEgY3lC d1lYSjBibS BWeWMyaHBj SE1nIFlXNW tJR052Ykcg eGhZbTl5WV hScCBiMjV6 SUhkcGRHIG dnYjNSb1pY SWcgY0doaG NtMWhZMiBW MWRHbGpZV3 dnIFkyOXRj R0Z1YVcgVn pMQ0JoWTJG ayBaVzFwWX lCcGJuIE4w YVhSMWRHbH YgYm5Nc0lH RnVaQyBCeV pYTmxZWEpq IGFDQnZjbW RoYm0gbDZZ WFJwYjI1ei BManhpY2o0 NUxpIEJVYU dVZ1kyOXQg Y0dGdWVTQm hiSCBOdklH aGhjeUJoIE lITjBjbTl1 WnkgQm1iMk 4xY3lCdiBi aUJwYm01dm RtIEYwYVc5 dUlHRnUgWk NCcGJuWmxj MyBSeklHaG xZWFpwIGJI a2dhVzRnY2 0gVnpaV0Z5 WTJnZyBZVz VrSUdSbGRt IFZzYjNCdF pXNTAgTGlC SmJpQXlNRC BJd0xDQnBk Q0J6IGNHVn VkQ0J2ZG0g VnlJQ1EwSU dKcCBiR3hw YjI0Z2IyID RnVWlaRUxq eGkgY2o0eE 1DNGdWRyBG clpXUmhJR2 hoIGN5QmhJ SEpwWTIgZ2 dhR2x6ZEc5 eSBlU0JoYm 1RZ2FHIEZ6 SUhCc1lYbG wgWkNCaElI TnBaMiA1cF ptbGpZVzUw IElISnZiR1 VnYVcgNGdk R2hsSUdSbC BkbVZzYjNC dFpXIDUwSU c5bUlIUm8g WlNCd2FHRn liVyBGalpY VjBhV05oIG JDQnBibVIx YzMgUnllU0 JwYmlCSyBZ WEJoYmk0Z1 NYIFFnYUdG eklHSmwgWl c0Z2NtVmpi MiBkdWFYcG xaQ0IzIGFY Um9JRzUxYl cgVnliM1Z6 SUdGMyBZWE prY3lCaGJt IFFnYUc5dW IzSnogSUc5 MlpYSWdkRy BobElIbGxZ WEp6IExqeG ljajR4TVMg NGdWR0ZyWl dSaCBJR2ho Y3lCaElHIE 52Y25CdmNt RjAgWlNCd2 FHbHNiMyBO dmNHaDVJR0 5oIGJHeGxa Q0JVWVcgdG xaR0V0YVhO dCBMQ0IzYU dsamFDIEJs YlhCb1lYTn AgZW1WeklI Um9aUyBCam IyMXdZVzU1 IDRvQ1pjeU JqYjIgMXRh WFJ0Wlc1MC BJSFJ2SUhC aGRHIGxsYm 5SekxDQmwg YlhCc2IzbG xaWCBNc0lH RnVaQ0J6IG IyTnBaWFI1 TGogeGljaj R4TWk0ZyBW R2hsSUdOdm JYIEJoYm5r Z2FHRnogSU daaFkyVmtJ RyBOb1lXeH NaVzVuIFpY TWdhVzRnY2 0gVmpaVzUw SUhsbCBZWE p6TENCcGJt IE5zZFdScG JtY2cgY0dG MFpXNTBJRy BWNGNHbHlZ WFJwIGIyNX pJR0Z1WkMg QnNaV2RoYk NCcCBjM04x WlhNZ2NtIF ZuWVhKa2FX NW4gSUhOdm JXVWdiMiBZ Z2FYUnpJRz FsIFpHbGpZ WFJwYjIgNX pMaUJJYjNk bCBkbVZ5TE NCcGRDIEJq YjI1MGFXNT EgWlhNZ2RH OGdZbSBVZ1 lTQnRZV3B2 IGNpQndiR0 Y1WlggSWdh VzRnZEdobC BJR2RzYjJK aGJDIEJ3YU dGeWJXRmog WlhWMGFXTm hiQyBCdFlY SnJaWFF1IF BHSnlQakV6 TGkgQkpiaU F5TURJeCBM Q0JVWVd0bF pHIEVnWVc1 dWIzVnUgWT JWa0lHbDBj eSBCcGJuUm xiblJwIGIy NGdkRzhnWW 0gVmpiMjFs SUdFZyBaMn h2WW1Gc0lH IHhsWVdSbG NpQnAgYmlC eVlYSmxJRy BScGMyVmhj MlZ6IElIZH BkR2dnWVMg Qm5iMkZzSU hSdiBJR3ho ZFc1amFDIE F6TUNCeVlY SmwgSUdScG MyVmhjMiBV Z2RHaGxjbU Z3IGFXVnpJ R0o1SUQgSX dNekF1UEdK eSBQakUwTG lCVVlXIHRs WkdFZ2FYTW cgWVd4emJ5 QnJibSA5M2 JpQm1iM0ln IGFYUnpJSE 4wY20gOXVa eUJqYjNKdy BiM0poZEdV Z1kzIFZzZE hWeVpTQmgg Ym1RZ2FHRn pJRyBKbFpX NGdjbVZqIG IyZHVhWHBs WkMgQmhjeU J2Ym1VZyBi MllnZEdobE lIIGR2Y214 azRvQ1ogY3 lCdGIzTjBJ RyBGa2JXbH laV1FnIFky OXRjR0Z1YV cgVnpJR0o1 SUVadiBjbl IxYm1VZ1RX IEZuWVhwcG JtVWcgWm05 eUlERXdJRy BOdmJuTmxZ M1YwIGFYWm xJSGxsWVgg SnpManhpY2 o0eCBOUzRn U1c0Z1lXIF JrYVhScGIy NGcgZEc4Z2 NHaGhjbSAx aFkyVjFkR2 xqIFlXeHpM Q0JVWVcgdG xaR0VnYVhN ZyBZV3h6Yn lCcGJuIFp2 YkhabFpDQn AgYmlCMllY SnBiMyBWek lHOTBhR1Z5 IElHSjFjMm x1WlggTnpa WE1zSUdsdS BZMngxWkds dVp5IEJtYj I5a0lIQnkg YjJSMVkzUn pMQyBCb1pX RnNkR2dnIF lXNWtJR0ps WVggVjBlU0 J6ZFhCdyBi R1Z0Wlc1MG N5IHdnWVc1 a0lHMWwgWk dsallXd2da RyBWMmFXTm xjeTQ9CiAg ICAgICAgPC 9zcGFuPgog ICAgICAgIA ogICAgICAg IA==
See Company Q&A
Takeda Pharmaceutical

πŸ“Š Get full analytics about Takeda Pharmaceutical

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal